Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajesh Balkrishnan

Showing results (51-60 of 320) with videos related to

Pageof 32
Sort By:
Expert Opinion on Drug Delivery|August 7, 2012
Topical drug delivery systems in dermatology: a review of patient adherence issuesXi Tan, Steven R Feldman, Jongwha Chang, et al.
Journal of Drugs in Dermatology : JDD|March 22, 2007
Outcomes associated with the use of biologic agents in moderate to severe psoriasisJessica Price, Monali Bhosle, Steven R Feldman, et al.
Journal of Primary Care & Community Health|June 28, 2013
Toward Continuous Primary Care in the United States: Differences in Patient Satisfaction Between First and Return Visits to Primary Care Physicians/Analysis of DrScore--The National e-Survey DataAla I Iaconi, Jongwha Chang, Steve Feldman, et al.
Journal of the American College of Surgeons|September 4, 2007
Economic evaluation of carotid artery stenting versus carotid endarterectomy for the treatment of carotid artery stenosisManjiri Pawaskar, Bhagwan Satiani, Rajesh Balkrishnan, et al.
Health Services Research|July 3, 2004
Trust in insurers and access to physicians: associated enrollee behaviors and changes over timeRajesh Balkrishnan, Mark A Hall, Stephen Blackwelder, et al.
Current Medical Research and Opinion|November 24, 2007
Treatment and costs associated with anemic chronic kidney disease patientsRafia S Rasu, Tonya Crawford, Harold Manley, et al.
The Journal of Dermatological Treatment|July 25, 2008
Severity levels in psoriasis: a separate 'very severe' category not requiredAmit S Kulkarni, Elizabeth Horn, Rajesh Balkrishnan, et al.
Health Affairs (Project Hope)|March 20, 2002
How disclosing HMO physician incentives affects trustMark A Hall, Elizabeth Dugan, Rajesh Balkrishnan, et al.
Research in Social & Administrative Pharmacy : RSAP|September 2, 2019
Examining factors associated with adherence to hormonal therapy in breast cancer patientsChintal H Shah, Rajesh Balkrishnan, Vakaramoko Diaby, et al.
The Journal of Dermatological Treatment|December 7, 2007
A role for denial in poor adherence to psoriasis treatmentFarah C Awadalla, Brad Yentzer, Rajesh Balkrishnan, et al.
Pageof 32

Showing results (51-60 of 320) with videos related to

Sort By:
Pageof 32
Expert Opinion on Drug Delivery|August 7, 2012
Topical drug delivery systems in dermatology: a review of patient adherence issuesXi Tan, Steven R Feldman, Jongwha Chang, et al.
Journal of Drugs in Dermatology : JDD|March 22, 2007
Outcomes associated with the use of biologic agents in moderate to severe psoriasisJessica Price, Monali Bhosle, Steven R Feldman, et al.
Journal of Primary Care & Community Health|June 28, 2013
Toward Continuous Primary Care in the United States: Differences in Patient Satisfaction Between First and Return Visits to Primary Care Physicians/Analysis of DrScore--The National e-Survey DataAla I Iaconi, Jongwha Chang, Steve Feldman, et al.
Journal of the American College of Surgeons|September 4, 2007
Economic evaluation of carotid artery stenting versus carotid endarterectomy for the treatment of carotid artery stenosisManjiri Pawaskar, Bhagwan Satiani, Rajesh Balkrishnan, et al.
Health Services Research|July 3, 2004
Trust in insurers and access to physicians: associated enrollee behaviors and changes over timeRajesh Balkrishnan, Mark A Hall, Stephen Blackwelder, et al.
Current Medical Research and Opinion|November 24, 2007
Treatment and costs associated with anemic chronic kidney disease patientsRafia S Rasu, Tonya Crawford, Harold Manley, et al.
The Journal of Dermatological Treatment|July 25, 2008
Severity levels in psoriasis: a separate 'very severe' category not requiredAmit S Kulkarni, Elizabeth Horn, Rajesh Balkrishnan, et al.
Health Affairs (Project Hope)|March 20, 2002
How disclosing HMO physician incentives affects trustMark A Hall, Elizabeth Dugan, Rajesh Balkrishnan, et al.
Research in Social & Administrative Pharmacy : RSAP|September 2, 2019
Examining factors associated with adherence to hormonal therapy in breast cancer patientsChintal H Shah, Rajesh Balkrishnan, Vakaramoko Diaby, et al.
The Journal of Dermatological Treatment|December 7, 2007
A role for denial in poor adherence to psoriasis treatmentFarah C Awadalla, Brad Yentzer, Rajesh Balkrishnan, et al.
Pageof 32